Inotuzumab ozogamicin: a CD22 mAb–drug conjugate for adult relapsed or refractory B-cell precursor acute lymphoblastic leukemia

Yurkiewicz IR, Muffly L, Liedtke M

Drug Design, Development and Therapy 2018, 12:2293-2300

Published Date: 24 July 2018